ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB)

Historical Holders from Q1 2017 to Q3 2025

Symbol
ANAB on Nasdaq
Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
27.7M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
31.6M
Holdings value
$969M
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
164
Number of buys
75
Number of sells
-75
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Point72 Asset Management, L.P. 7.7% +35% $49M $14M 2.37M +40% Point72 Asset Management, L.P. 31 Mar 2025
BlackRock, Inc. 6.2% -27.5% $39.3M -$13.4M 1.9M -25.4% BlackRock, Inc. 31 Mar 2025
MORGAN STANLEY 6.3% $48.1M 1.85M Morgan Stanley 30 Jun 2025
VANGUARD GROUP INC 5.23% +5.8% $34.1M $449K 1.54M +1.33% The Vanguard Group 30 Jun 2025
MILLENNIUM MANAGEMENT LLC 5.1% $28.9M 1.43M Millennium Management LLC 16 Sep 2025
GOLDMAN SACHS GROUP INC 4.5% -14% $38.3M -$10.3M 1.25M -21.2% THE GOLDMAN SACHS GROUP, INC. 30 Sep 2025
First Light Asset Management, LLC 3.12% -57.4% $26.5M -$42.9M 865K -61.8% Mathew P. Arens 30 Sep 2025
FMR LLC 0.9% -88.3% $5.09M -$33.1M 254K -86.7% FMR LLC 30 May 2025

Institutional Holders of ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 31.6M $969M -$154M $30.62 164
2025 Q2 36.8M $816M -$61.5M $22.20 146
2025 Q1 40M $743M +$107M $18.59 150
2024 Q4 35.4M $469M -$87.9M $13.24 133
2024 Q3 33.6M $1.13B +$123M $33.50 158
2024 Q2 29.8M $747M +$18.4M $25.06 133
2024 Q1 29.2M $658M -$21M $22.52 132
2023 Q4 30.2M $646M +$662K $21.42 117
2023 Q3 30.3M $545M -$1.74M $17.96 116
2023 Q2 30.2M $615M -$16.3M $20.34 116
2023 Q1 31M $675M -$44.7M $21.76 112
2022 Q4 32.9M $1.02B -$10.5M $30.99 114
2022 Q3 32.6M $831M +$39.4M $25.51 109
2022 Q2 31.2M $633M +$28.5M $20.30 117
2022 Q1 29.7M $735M +$14M $24.74 124
2021 Q4 27.8M $964M +$8.86M $34.75 132
2021 Q3 27.6M $749M -$4.36M $27.12 123
2021 Q2 27.8M $721M -$34.1M $25.93 117
2021 Q1 29.2M $629M +$26.2M $21.55 116
2020 Q4 27.9M $601M -$16.7M $21.50 129
2020 Q3 29.1M $430M -$16.5M $14.75 127
2020 Q2 30M $670M -$17.2M $22.34 117
2020 Q1 31.2M $441M +$44.1M $14.13 112
2019 Q4 28.3M $460M -$211M $16.25 119
2019 Q3 29M $1.02B -$48.9M $34.99 118
2019 Q2 30.2M $1.7B +$118M $56.42 126
2019 Q1 29.1M $2.13B +$19.4M $73.05 128
2018 Q4 29M $1.85B -$11.2M $63.79 120
2018 Q3 28.6M $2.85B +$379M $99.77 127
2018 Q2 24.9M $1.77B +$926K $71.04 121
2018 Q1 24.3M $2.53B +$62.8M $104.08 134
2017 Q4 23.8M $2.39B +$693M $100.72 116
2017 Q3 17.7M $620M +$143M $34.95 70
2017 Q2 13.7M $328M -$2.48M $23.93 51
2017 Q1 13.8M $382M +$375M $27.75 48